243 related articles for article (PubMed ID: 34651254)
1. Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis.
Lorona NC; Malone KE; Li CI
Breast Cancer Res Treat; 2021 Dec; 190(3):549-558. PubMed ID: 34651254
[TBL] [Abstract][Full Text] [Related]
2. A Contemporary Analysis of Racial and Ethnic Disparities in Diagnosis of Early-Stage Breast Cancer and Stage-Specific Survival by Molecular Subtype.
Primm KM; Zhao H; Hernandez DC; Chang S
Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1185-1194. PubMed ID: 35314859
[TBL] [Abstract][Full Text] [Related]
3. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
5. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
6. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
Tao L; Gomez SL; Keegan TH; Kurian AW; Clarke CA
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1039-45. PubMed ID: 25969506
[TBL] [Abstract][Full Text] [Related]
8. Disparities in mortality-to-incidence ratios by race/ethnicity for female breast cancer in New York City, 2002-2016.
Nobel TB; Asumeng CK; Jasek J; Van Beck KC; Mathur R; Qiao B; Brown JJ
Cancer Med; 2020 Nov; 9(21):8226-8234. PubMed ID: 33006431
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
[TBL] [Abstract][Full Text] [Related]
10. Racial and ethnic disparities in treatment-related heart disease mortality among US breast cancer survivors.
Vo JB; Ramin C; Lawrence WR; Barac A; Ho KL; Rhee J; Veiga LHS; Berrington de González A
JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36943362
[TBL] [Abstract][Full Text] [Related]
11. Impact of molecular subtype and race on HR+, HER2- breast cancer survival.
Reid S; Haddad D; Tezak A; Weidner A; Wang X; Mautz B; Moore J; Cadiz S; Zhu Y; Zheng W; Mayer IA; Shu XO; Pal T
Breast Cancer Res Treat; 2021 Oct; 189(3):845-852. PubMed ID: 34331630
[TBL] [Abstract][Full Text] [Related]
12. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
Shubeck S; Zhao F; Howard FM; Olopade OI; Huo D
JAMA Netw Open; 2023 Mar; 6(3):e235834. PubMed ID: 36995711
[TBL] [Abstract][Full Text] [Related]
13. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
Parise C; Caggiano V
Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
[TBL] [Abstract][Full Text] [Related]
14. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.
Zhang L; King J; Wu XC; Hsieh MC; Chen VW; Yu Q; Fontham E; Loch M; Pollack LA; Ferguson T
Cancer Epidemiol; 2019 Feb; 58():1-7. PubMed ID: 30415099
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.
Sung H; Nisotel L; Sedeta E; Islami F; Jemal A
JAMA Netw Open; 2023 Aug; 6(8):e2327429. PubMed ID: 37540510
[TBL] [Abstract][Full Text] [Related]
17. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
[TBL] [Abstract][Full Text] [Related]
19. Racial/Ethnic Disparities in Survival Among Women Diagnosed with Invasive Cancer of the Anal Canal: an Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.
Stenzel AE; Schlecht NF; Moysich KB
J Gastrointest Cancer; 2021 Sep; 52(3):854-862. PubMed ID: 32803517
[TBL] [Abstract][Full Text] [Related]
20. Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health.
Hung MC; Ekwueme DU; Rim SH; White A
Cancer Epidemiol; 2016 Dec; 45():112-118. PubMed ID: 27792934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]